Back to Market Feed

APREPITANT 125 MG CAPSULE

Aprepitant
$117.0810per EA

Strength

125 mg/1

NDC

68001066819

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

APREPITANT

Approval Type

Generic (ANDA)

FDA Application

ANDA207777

On Market Since

12/1/2025

Pharmacological Classes

Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Cytochrome P450 3A4 Inhibitors
Neurokinin 1 Antagonists
Substance P/Neurokinin-1 Receptor Antagonist

Price History

1W

0.0%

1M

-3.4%

3M

-19.1%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.1%

Generic Alternatives

1 alternative • Same active ingredient

APREPITANT 125 MG CAPSULE
Generic
68462058576•Glenmark Pharmaceuticals Inc., USA
$117.0815

Related Drugs

Same classification

TOPIRAMATE 25 MG TABLET
Generic
00904692861•Major Pharmaceuticals
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011505•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011510•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
29300011516•Unichem Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070713•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
47335070786•Sun Pharmaceutical Industries Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
65862017160•Aurobindo Pharma Limited
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68084034201•American Health Packaging
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013805•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA
TOPIRAMATE 25 MG TABLET
Generic
68382013814•Zydus Pharmaceuticals (USA) Inc.
$0.0257
per EA